Inflammatory markers in children and adolescents with type 2 diabetes mellitus

Area of Science:

• Pediatric Endocrinology
• Immunology
• Metabolic Diseases

Background:

• Type 2 Diabetes Mellitus (T2DM) is increasingly diagnosed in pediatric populations.
• Inflammation is implicated in T2DM pathogenesis and complications.
• Understanding pediatric T2DM requires examining factors beyond insulin resistance and aging.

Purpose of the Study:

• To review the association between serum inflammation markers and T2DM in children and adolescents.
• To explore the role of inflammation in pediatric T2DM development and beta-cell failure.
• To identify potential therapeutic targets by modulating inflammatory processes.

Main Methods:

• Systematic review of pediatric studies on inflammation markers and T2DM.
• Analysis of pro-inflammatory and anti-inflammatory cytokine profiles in insulin resistance and T2DM.
• Focus on studies excluding confounding factors like comorbidities and smoking.

Main Results:

• Elevated pro-inflammatory cytokines (TNF-α, IL-6, IL-1β, IFNγ, PEDF, fetuin A) observed in pediatric insulin resistance.
• Decreased anti-inflammatory cytokines (adiponectin, omentin) noted in pediatric insulin resistance.
• Specific alterations in TNF-α, fetuin A, and FGF-21 in obese children with T2DM suggest direct beta-cell involvement.

Conclusions:

• Inflammation plays a significant role in the pathophysiology of T2DM in children and adolescents.
• Altered cytokine profiles contribute to beta-cell dysfunction in young individuals with T2DM.
• Further research in pediatric populations can enhance understanding of T2DM as an inflammatory disease.